The carrier function and inhibition effect on benign prostatic hyperplasia of a glucan from Epimedium brevicornu Maxim
- PMID: 38858029
- DOI: 10.1016/j.carbpol.2024.122316
The carrier function and inhibition effect on benign prostatic hyperplasia of a glucan from Epimedium brevicornu Maxim
Abstract
Epimedium, a traditional Chinese medicine commonly used as a dietary supplement, contains polysaccharides and flavonoids as its main bioactive ingredients. In this study, a neutral homogeneous polysaccharide (EPSN-1) was isolated from Epimedium brevicornu Maxim. EPSN-1 was identified as a glucan with a backbone of →4)-α-D-Glcp-(1→, branched units comprised α-D-Glcp-(1→6)-α-D-Glcp-(1→, β-D-Glcp-(1→6)-β-D-Glcp-(1→ and α-D-Glcp-(1→ connected to the C6 position of backbone. The conformation of EPSN-1 in aqueous solution indicated its potential to form nanoparticles. This paper aims to investigate the carrier and pharmacodynamic activity of EPSN-1. The findings demonstrated that, on the one hand, EPSN-1, as a functional ingredient, may load Icariin (ICA) through non-covalent interactions, improving its biopharmaceutical properties such as solubility and stability, thereby improving its intestinal absorption. Additionally, as an effective ingredient, EPSN-1 could help maintain the balance of the intestinal environment by increasing the abundance of Parabacteroides, Lachnospiraceae UGG-001, Anaeroplasma, and Eubacterium xylanophilum group, while decreasing the abundance of Allobaculum, Blautia, and Adlercreutzia. Overall, this dual action of EPSN-1 sheds light on the potential applications of natural polysaccharides, highlighting their dual role as carriers and contributors to biological activity.
Keywords: Compatibility; Epimedium polysaccharide; Gut microbiota; Icariin; Structural characterization.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Comparing the pharmacological effects of the prepared folium of Epimedium brevicornu Maxim. and Epimedium sagittatum Maxim. on kidney-Yang deficiency syndrome and liver injury complications.Fitoterapia. 2024 Jul;176:106006. doi: 10.1016/j.fitote.2024.106006. Epub 2024 May 12. Fitoterapia. 2024. PMID: 38744386
-
Advancements in the Biotransformation and Biosynthesis of the Primary Active Flavonoids Derived from Epimedium.Molecules. 2023 Oct 19;28(20):7173. doi: 10.3390/molecules28207173. Molecules. 2023. PMID: 37894651 Free PMC article. Review.
-
Liver protecting effects and molecular mechanisms of icariin and its metabolites.Phytochemistry. 2023 Nov;215:113841. doi: 10.1016/j.phytochem.2023.113841. Epub 2023 Sep 1. Phytochemistry. 2023. PMID: 37660725 Review.
-
Simultaneous Preparation and Comparison of the Osteogenic Effects of Epimedins A - C and Icariin from Epimedium brevicornu.Chem Biodivers. 2018 Apr;15(4):e1700578. doi: 10.1002/cbdv.201700578. Epub 2018 Apr 10. Chem Biodivers. 2018. PMID: 29451707
-
STUDY ON THE DIFFERENCES OF MAJOR PHARMACEUTICAL INGREDIENTS IN DIFFERENT PARTS AND PROCESSED MEDICINAL MATERIAL OF EPIMEDIUM BREVICORNU MAXIM IN TAIHANG MOUNTAIN.Nutr Hosp. 2015 Aug 1;32(2):913-7. doi: 10.3305/nh.2015.32.2.8927. Nutr Hosp. 2015. PMID: 26268128
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous